Back to AZNView Full Landscape
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
12 competitors in Ovarian Cancer
ZNTLazenosertib
IMNNIMNN-001
Phase 3CLRBNOV-002
Phase 2CASIENMD-2076
Phase 2SGENtisotumab vedotin
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
